Mukka Proteins Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

380.61

653.50

244.58

170.77

381.57

303.15

149.20

Other Operating Income

0.00

Total Operating income

380.61

653.50

244.58

170.77

381.57

303.15

149.20

Raw Material Cost

375.46

581.97

280.45

192.85

254.60

341.86

129.23

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-75.08

-31.02

-91.78

-63.52

57.32

-120.97

-16.97

Employee Cost

13.13

10.82

8.94

7.89

8.57

8.43

8.31

Power Cost

0.00

Manufacturing Expenses

0.00

0.01

0.00

-0.01

0.00

Selling and Distribution Expenses

0.00

Other Expenses

33.23

46.29

26.23

19.00

31.92

32.48

19.06

Total Expenditure (Excl Depreciation)

346.74

608.06

223.85

156.22

352.40

261.80

139.63

Operating Profit (PBDIT) excl Other Income

33.87

45.44

20.73

14.55

29.17

41.35

9.57

Other Income

15.19

4.93

6.00

2.56

4.15

5.80

3.14

Operating Profit (PBDIT)

49.06

50.37

26.73

17.11

33.32

47.15

12.71

Interest

15.17

14.56

12.82

11.04

10.32

10.91

8.72

Exceptional Items

0.00

Gross Profit (PBDT)

33.89

35.81

13.91

6.07

23.00

36.24

3.99

Depreciation

5.13

4.03

4.18

3.26

2.82

3.80

3.76

Profit Before Tax

28.89

34.62

9.28

2.36

20.10

32.97

1.05

Tax

7.53

7.37

2.39

0.77

6.10

6.17

-0.42

Provisions and contingencies

0.00

Profit After Tax

21.23

24.41

7.33

2.04

14.09

26.28

0.64

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

21.23

24.41

7.33

2.04

14.09

26.28

0.64

Share in Profit of Associates

0.13

2.84

-0.45

-0.09

0.52

0.83

Minority Interest

0.74

3.51

1.01

0.07

0.41

0.54

-0.61

Other related items

0.00

Consolidated Net Profit

20.62

23.75

5.88

1.52

13.59

26.26

2.08

Equity Capital

30.00

Face Value

1.0

Reserves

0.00

Earnings per share (EPS)

0.69

0.79

0.2

0.05

0.45

0.88

0.07

Diluted Earnings per share

0.69

0.79

0.2

0.05

0.45

0.88

0.07

Operating Profit Margin (Excl OI)

9.21%

7.16%

8.78%

8.82%

7.84%

13.96%

6.61%

Gross Profit Margin

9.21%

5.64%

5.89%

3.68%

6.18%

12.23%

2.75%

PAT Margin

5.81%

4.29%

2.91%

0.96%

3.76%

9.05%

1.01%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -41.76% vs 167.19% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -13.18% vs 303.91% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -25.46% vs 119.20% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is 4.19% vs 13.57% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Mukka Proteins With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

380.61

445.45

-64.84

-14.56%

Other Operating Income

0.00

Total Operating income

380.61

445.45

-64.84

-14.56%

Raw Material Cost

375.46

7.78

367.68

4,725.96%

Purchase of Finished goods

0.00

7.68

-7.68

-100.00%

(Increase) / Decrease In Stocks

-75.08

112.74

-187.82

-166.60%

Employee Cost

13.13

206.13

-193.00

-93.63%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

33.23

103.38

-70.15

-67.86%

Total Expenditure (Excl Depreciation)

346.74

437.71

-90.97

-20.78%

Operating Profit (PBDIT) excl Other Income

33.87

7.74

26.13

337.60%

Other Income

15.19

0.14

15.05

10,750.00%

Operating Profit (PBDIT)

49.06

7.88

41.18

522.59%

Interest

15.17

43.66

-28.49

-65.25%

Exceptional Items

0.00

Gross Profit (PBDT)

33.89

-35.78

69.67

194.72%

Depreciation

5.13

15.07

-9.94

-65.96%

Profit Before Tax

28.89

-50.85

79.74

156.81%

Tax

7.53

-14.44

21.97

152.15%

Provisions and contingencies

0.00

Profit After Tax

21.23

-36.41

57.64

158.31%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

21.23

-36.41

57.64

158.31%

Share in Profit of Associates

0.13

0.00

0.13

Minority Interest

0.74

0.00

0.74

Other related items

0.00

Consolidated Net Profit

20.62

-36.41

57.03

156.63%

Equity Capital

30.00

52.23

-22.23

-42.56%

Face Value

1.00

5.00

0.00

Reserves

0.00

Earnings per share (EPS)

0.69

-3.49

4.18

119.77%

Diluted Earnings per share

0.69

-3.48

4.17

119.83%

Operating Profit Margin (Excl OI)

9.21%

1.74%

0.00

7.47%

Gross Profit Margin

9.21%

-8.03%

0.00

17.24%

PAT Margin

5.81%

-8.17%

0.00

13.98%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 380.61 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -41.76% vs 167.19% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -0.25% vs 48.64% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 20.62 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -13.18% vs 303.91% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 51.73% vs -49.98% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 33.87 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -25.46% vs 119.20% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 16.11% vs -9.38% in Mar 2025

Quarterly - Interest

Interest 15.17 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 4.19% vs 13.57% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 47.00% vs 55.66% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 9.21%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025